CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · IEX Real-Time Price · USD
+1.09 (1.92%)
At close: Jul 12, 2024, 4:00 PM
+0.87 (1.50%)
Pre-market: Jul 15, 2024, 7:26 AM EDT

CRISPR Therapeutics AG Revenue

CRISPR Therapeutics AG had revenue of $271.71M in the twelve months ending March 31, 2024, with 171.01% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $504.00K. In the year 2023, CRISPR Therapeutics AG had annual revenue of $371.21M with 30,885.48% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
4.92B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023371.21M370.01M30,885.48%
Dec 31, 20221.20M-913.77M-99.87%
Dec 31, 2021914.96M914.24M127,154.94%
Dec 31, 2020719.00K-288.87M-99.75%
Dec 31, 2019289.59M286.47M9,169.85%
Dec 31, 20183.12M-37.87M-92.38%
Dec 31, 201741.00M35.83M693.90%
Dec 31, 20165.16M4.92M1,990.69%
Dec 31, 2015247.00K--
Dec 31, 20140--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Select Medical Holdings 6.79B
Option Care Health 4.43B
PACS Group 3.34B
Haemonetics 1.31B
Merit Medical Systems 1.28B
Apellis Pharmaceuticals 524.07M
Doximity 475.42M
TransMedics Group 296.92M
Revenue Rankings